No thanks! I would like to know more about CHROMacademy

 Over 3000 E-Learning topics / 5000 Articles & Applications
 

The CHROMacademy Essential Guide Webcast:
Techniques Employed in Biopharmaceutical Analysis – Part I Reversed Phase and HILIC
 
 

Thursday 19th March 2015

Biopharmaceuticals offer great new possibilities and potential in treating various life threatening diseases such as cancer and autoimmune diseases. However, their complexity, resulting from their heterogeneity, represents a great challenge to the analytical chemist and a suite of techniques is required for their characterization and analysis. Reversed phase chromatography, the mainstay of traditional small molecule analysis, is employed at multiple biopharmaceutical levels due to its versatility, inherent relative efficiency and ease of hyphenation to a mass spectrometer. However, these separations often rely on finely balanced critical parameters being correctly optimized. We shall interrogate these critical parameters at each level and discuss best practices for implementation and optimization. The considerable increase in glycosylated biopharmaceuticals and the development of biosimilars and biobetters has led to much greater interest in the type and degree of glycosylation. We will review not only the popularity behind glycosylated biopharmaceuticals but where the heterogeneity comes from and how glycans can be effectively liberated, characterized and analyzed using HILIC.

Presented by Dr. Koen Sandra (The Research Institute of Chromatography, RIC) and
Scott Fletcher (Technical Business Development Manager, Crawford Scientific).

  • Reversed Phase (RP) chromatography is commonly used to analyze at the following levels;
    • Intact biopharmaceuticals
    • Biopharma fragments
    • Biopharma degradants/modifications
    • Peptides
    • Amino acids
  • Why is RP so popular and how does it work?
  • How is it employed at each level?
  • How are methods developed and optimized?
  • HILIC is becoming the technique of choice for glycan and polar peptide analysis
    • Why is analyzing glycans so important?
    • How does HILIC work in the analysis of glycans?
    • How are HILIC methods developed, optimized and made robust?

Key Learning Objectives:

  • Why reversed phase chromatography is popular at multiple levels of biopharmaceutical analysis and characterization
  • How reversed phase chromatography is employed at theses different levels and how methods can be developed and optimized
  • Why HILIC has become the technique of choice for analyzing and characterizing glycans and glycosylated species and polar peptides
  • Typical approaches and best practices for liberation, labelling, analysis and cauterization of glycans and polar peptides

Who Should Attend:

  • All analytical scientists
  • Anyone who currently analyzes or is interested in analyzing biopharmaceuticals
  • Anyone interested in protein analysis or proteomics

Find out more about this Month's Essential Guide Webcast »

 
 

Techniques Employed in Biopharmaceutical Analysis - Part I: Reversed Phase and HILIC

Biopharmaceuticals offer great new possibilities and potential in treating various life threatening diseases such as cancer and autoimmune diseases.  However, their complexity, resulting from their heterogeneity, represents a great challenge to the analytical chemist and a suite of techniques is required for their characterization and analysis. 

Reversed phase chromatography, the mainstay of traditional small molecule analysis, is employed at multiple biopharmaceutical levels due to its versatility, inherent relative efficiency and ease of hyphenation to a mass spectrometer.  However, these separations often rely on finely balanced critical parameters being correctly optimized.  We shall interrogate these critical parameters at each level and discuss best practices for implementation and optimization.  The considerable increase in glycosylated biopharmaceuticals and the development of biosimilars and biobetters has led to much greater interest in the type and degree of glycosylation. 

We will review not only the popularity behind glycosylated biopharmaceuticals but where the heterogeneity comes from and how glycans can be effectively liberated, characterized and analyzed using HILIC.

Watch the webcast and delve into our CHROMacademy material to further your knowledge of biopharmaceutical analysis.

Share this tutorial

eLearning Modules

 
Fundamentals of MS Proteomics Research Introduction to Ion Chromatography

This e-learning module introduces the working principles of ion chromatography and highlights the various approaches to analyzing ions in solution.

Types of Ion Chromatography | General Ion Exchange Considerations | Ion Exchange Elution Considerations

Ion Exclusion Chromatography | The Ion Chromatographic System | Hyphenated Ion Chromatography

 
Fundamentals of MS Proteomics Research

This CHROMacademy elearning module will introduce the basic principles of proteomic mass spectrometric analysis of simple biomolecules. The soft ionization techniques employed for proteomics research are presented in order to provide a good basic understanding of the mass spectrometric instrumentation and process. Finally, the interpretation of mass spectra will also be covered to provide the complete basic introduction to proteomics research.

Mechanism of Reversed Phase HPLC | Changing the Organic Modifier | Reversed Phase HPLC of Ionizable Samples

Buffers for Reversed Phase HPLC | Henderson-Hasselbalch Equation

 
*NEW* Biopharmaceutical Analysis Module - Coming Soon!
in association with the Research Institute of Chromatography (Kortrijk, Belgium)

CHROMacademy are delighted to announce our forthcoming BioChromatography module covering all aspects of biopharmaceutical analysis. This major new multimedia e-learning module is being written in conjunction with the Research Institute of Chromatography (RIC), a world renowned authority on the subject. The new module will provide a thorough introduction to biopharmaceuticals and their development and will consider all aspects of chromatographic and mass spectrometric analysis of intact, modified, aggregated, charged, degraded, digested, and reduced biopharmaceuticals. The module will not only include relevant theory but will be packed with interactive movies and animations to make the learning as practically relevant as possible for those currently involved in or wishing to enter bio-pharmaceutical analysis.

The topics included will be:

  • Global Pharmaceutical Market Overview
  • Basics of Protein BioChemistry - Amino Acids
  • Basics of Protein BioChemistry - Proteins
  • Monoclonal Antibiodies (mAb) in Bipharmaceuticals
  • Monoclonal Antibiodies - Form and Function
  • Protein Development and Manufacture
  • Biopharmaceuticals - Advances in Efficacy and Safety
 
  • Trastuzumab - A Model Monoclonal Antibody (mAb)
  • Trastuzumab - Production and Characteristics
  • Trastuzumab - Common Post Translational Modifications
  • Common mAb Post Translation Modifications (PTM’s)
  • Analytical Characterization at the Protein Level
  • Reversed Phase HPLC Analysis of Intact and Reduced Proteins
  • Chromatographic Requirements
  • Chemical Derivatization
 
 
HPLC Techniques in Biopharmaceutical Analysis

Biopharmaceuticals offer great hope in treating medical conditions which are currently poorly served at best by traditional pharmaceuticals. It is estimated that there are over 400 biopharmaceuticals in clinical trials for in excess of 200 disease areas. The enhanced complexity and variability that comes from the size of biopharmaceuticals, allied with the intricacy of the production process, mean chromatography is employed to a much greater extent during production and release testing. This Essential Guide webcast will provide details of why differing modes of chromatography are required in the research, preparation and analysis of biopharmaceuticals and when they would be typically used.

HPLC Techniques in Biopharmaceutical Analysis »

 
Characterization of Protein Biopharmaceuticals Characterization of Protein Biopharmaceuticals

Protein biopharmaceuticals such as monoclonal antibodies and recombinant proteins are currently in widespread use for treatment of various life-threatening diseases including cancer, autoimmune diseases, diabetes, anemia, etc. Protein therapeutics have a complexity far exceeding that of small molecule drugs, hence, unraveling this complexity represents an analytical challenge. This web seminar will highlight the power of liquid chromatography combined with mass spectrometry in the characterization of protein biopharmaceuticals.

Characterization of Protein Biopharmaceuticals »

 
Analysis of Post Translational Modifications Using LC-MS/MS The Analysis of Post Translational Modifications Using LC-MS/MS

In this session, Dr. Duncan Smith and Dr. John Griffiths (MS-Insight Ltd and Manchester University) explain the principles behind the analysis of a number of key post-translational modifications (PTMs) using LC-MS/MS techniques. They will begin with a brief overview of bottom-up proteomics, explaining how proteins are converted to peptides, which are then analyzed using electrospray LC-MS/MS. They will move on to talk about the various MS scanning techniques, which may be used for PTM analysis. Next, they will discuss in turn, how phosphorylation, acetylation, ubiquitination and SUMOylation may be analyzed using mass spectrometry, drawing upon examples from their own research at the University of Manchester. Finally, they will give their own opinions on the ways in which they see the future of PTM analysis heading.

The Analysis of Post Translational Modifications Using LC-MS/MS »

 
 
 
loading data
loading data
loading data
loading data
loading data
Home | About UsContact Us | SubscribeTerms and Conditions | Advertise | Privacy Policy |

loading data

loading data

loading data

 

loading data


loading data

  • Why reversed phase chromatography is popular at multiple levels of biopharmaceutical analysis and characterization
  • How reversed phases chromatography is employed at theses different levels and how methods can be developed and optimized
  • Why HILIC has become the technique of choice for analyzing and characterizing glycans and glycosylated species and polar peptides
  • Typical approaches and best practices for liberation, labelling, analysis and cauterization of glycans and polar peptides

Who Should Attend:

  • All analytical scientists
  • Anyone who currently analyzes or is interested in analyzing biopharmaceuticals
  • Anyone interested in protein analysis or proteomics

Dr. Koen Sandra
R&D Director Life Sciences, Research Institute for Chromatography (RIC)

 

Scott Fletcher
Technical Business Development Manager
Crawford Scientific